# EDETATE DISODIUM

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid5049576
Categories: beauty, cleaning, food, industrial, pharma
Functions: Antioxidant, Chelating agent, Flavouring and nutrient, Fragrance
Identifier: DTXSID5049576

> EDETATE DISODIUM is used as antioxidant / chelating agent. EPA CPDat observed this chemical in 171 composition records across product categories including Laboratory supplies, Food and drug, Pet and animal care. Assessed from 80 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 171 composition records across product categories including Laboratory supplies, Food and drug, Pet and animal care.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 171 composition records across product categories including Laboratory supplies, Food and drug, Pet and animal care. EPA CPDat classifies this chemical for functional uses including Fragrance, Antioxidant, Chelating agent.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: 0.05 %w/w
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.1 %w/v
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: INFILTRATION; Dosage form: INJECTION; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: INTRABURSAL; Dosage form: INJECTION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: INTRACARDIAC; Dosage form: INJECTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 10 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: 0.48 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 10 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 59 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: 0.4 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 19 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 7 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: LIQUID; Potency: 0.03 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: IONTOPHORESIS; Dosage form: SYSTEM; Potency: 0.1 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: DROPS; Potency: 0.1 mg/1ml
- US: inactive ingredient database — Route: NASAL; Dosage form: LIQUID; Potency: 2 mg/1ml
- US: inactive ingredient database — Route: NASAL; Dosage form: SOLUTION; Potency: 100 mg/100ml
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: DROPS; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.3 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: GEL; Maximum daily exposure: 396 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.13 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.06 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Potency: 1.3 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: LIQUID; Potency: 0.5 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 285 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 432 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 40 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 40 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 100 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.21 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 100 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EFFERVESCENT; Maximum daily exposure: 32 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 10 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: AEROSOL, FOAM; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: ENEMA; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: SOLUTION; Maximum daily exposure: 97 mg
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Maximum daily exposure: 43 mg
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SPRAY; Potency: 0.05 %w/w
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SUSPENSION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 0.05 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 14 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: EMULSION; Potency: 0.11 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 7 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 22 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO; Potency: 1 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO, SUSPENSION; Potency: 1 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 126 mg
- US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 5 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 2 active drug products and 2 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._